Insiders Spero Therapeutics, Inc.

Equities

SPRO

US84833T1034

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
1.62 ^USD	+1.25%		-2.99%	+10.20%

10:11pm	Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M	MT
Mar. 13	Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tamara Joseph Steps Down as Chief Legal Officer and Corporate Secretary of Spero Therapeutics, Inc, Effective as of March 6, 2024	Feb. 09	CI
Spero Therapeutics Appoints Esther Rajavelu Chief Financial Officer	Nov. 01	MT
Spero Therapeutics Appoints Esther Rajavelu as Chief Business Officer	Nov. 01	CI
Spero Therapeutics Names Satyavrat Shukla Chief Executive	23-06-14	MT
Spero Therapeutics, Inc. Announces Chief Executive Officer Changes	23-06-14	CI
Spero Therapeutics, Inc. Announces Executives Changes, Effective August 1, 2023	23-06-14	CI
Spero Therapeutics, Inc. Appoints Timothy Keutzer as Chief Operating Officer, Effective as of February 1, 2023	23-02-01	CI
Spero Therapeutics Announces Appointment of Kamal Hamed as Chief Medical Officer	22-09-15	CI
Spero Therapeutics, Inc. Announces Executive Changes	22-05-03	CI
Insider Buy: Spero Therapeutics	22-01-03	MT
Spero Therapeutics, Inc. Appoints Kathleen Tregoning to Its Board of Directors	21-10-12	CI
Insider Trends: Insider Prolongs Selling Trend at Spero Therapeutics	21-02-04	MT
Insider Trends: Selling By Insiders Lingers at Spero Therapeutics	20-12-18	MT
Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer, Effective as of January 4, 2021	20-12-17	CI
Spero Therapeutics, Inc. Appoints Tamara Joseph as Chief Legal Officer	20-12-02	CI
Insider Trends: Spero Therapeutics Insider Continues 90-Day Selling Trend	20-11-10	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Spero Therapeutics	20-11-06	MT
Spero Therapeutics, Inc. Appoints Scott Jackson to the Audit Committee of the Board, Effective May 15, 2020	20-05-11	CI
Spero Announces Appointment of Scott Jackson to Its Board of Directors	20-04-16	CI
Spero Therapeutics, Inc. Announces Step Down of David P. Southwell from its Board of Directors	19-04-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Spero Therapeutics, Inc.

Equities

SPRO

US84833T1034

Insiders

Filters